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Overall, 3,073 CVs in 1,790 patients with no periprocedural OAC were included in the current analysis.
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and 1 in 45.4% (n ¼ 1,395) patients. Hypertension
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accounted for the CHA2DS 2-VASc point in 60.9%
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(n ¼ 850), age (65 to 74 years) in 19.9% (n ¼ 278),
vascular disease in 15.6% (n ¼ 218), heart failure in
1.79% (n ¼ 25), and diabetes in 1.72% (n ¼ 24) of patients. A deﬁnite SSE occurred in 11 patients (8
ischemic strokes and 3 peripheral emboli) within
30 days from CV. The median age at the time of the
CV was 60 years (interquartile range: 51 to 64 years) in
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patients with an SSE and 56 years (interquartile
range: 48 to 61 years) in those without SSE. The
incidence of SSE was 0.14% (n ¼ 2; 95% conﬁdence
interval: 0.04 to 0.49) in patients cardioverted within
12 h from AF onset (n ¼ 1,478) and 0.56% (n ¼ 9; 95%
conﬁdence interval: 0.30% to 1.11%) in those cardioverted within 12 to 48 h (n ¼ 1,595) (p ¼ 0.067,
2-sided Fisher test).
Our study shows that CV performed within 12 h
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CV (4), because heart failure and diabetes were rare in
these low-risk patients. To put the risk level in
perspective, the risk of adverse events (composite of
stroke, systemic embolism, and major bleed) associated with CV performed during direct oral anticoagulant therapy ranges from 0.40% to 0.60% according
to randomized trials (Figure 1) (5). The risk of major
bleeds during the initiation phase of OAC therapy is

The COVID-19 Pandemic
and Acute Aortic
Dissections in New York
A Matter of Public Health

not negligible, even in patients at low risk, and it can

As of April 15, 2020, the number of conﬁrmed coro-

be avoided by refraining from short-term OAC.

navirus disease-2019 (COVID-19) cases in New York

In conclusion, our analyses from the large and

City (NYC) was >110,000, thus making it the global

comprehensive FinCV dataset are in line with the

epicenter of the pandemic (1). This rapid surge in the

AHA/ACC/HRS guideline recommendation. Perform-

number of cases imposed a major burden on all hos-

ing CV without OAC in patients with CHA 2DS2-VASc

pitals in NYC, as well as causing signiﬁcant stress in

of <2 and AF duration of <12 h carries a low risk of

emergency departments (EDs). In addition, public

SSE without the inherent bleeding risk associated

health messages promoting social distancing and

with OAC. In view of the known early development of

news reports focusing on the death toll associated

prothrombotic changes after arrhythmia onset, it

with COVID-19 have created a sense of generalized

seems reasonable to proceed to CV as early as possible

anxiety in society. Changes in the observed incidence

in patients without OAC.

of acute cardiovascular conditions have been anec-
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dotally

reported,

including

the

occurrence

of

ST-segment elevation myocardial infarctions (2).
Incidentally, the number of at-home deaths in NYC
has reached an 8- to 10-fold increase compared

227

JACC VOL. 76, NO. 2, 2020

Letters

228

JULY 14, 2020:226–31

F I G U R E 1 Trend of Type A Repair Volume
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Before COVID-19

COVID-19 Cases

Type AAD

(A) Variation in monthly volumes of surgically treated acute type A aortic dissections (AAD) (red line, left vertical axis) and coronavirus disease-2019 (COVID-19) cases
(blue bar, right vertical axis) in New York City from January 1, 2018 to April 15, 2020. (B) Decrease in average monthly volumes before and after COVID-19 (p < 0.05).

with the same time period in 2019, thereby raising

after–COVID-19 periods. The cutoff between before

concerns about the impact of the pandemic on

and after COVID-19 was March 1, 2020, corresponding

non–COVID-related health conditions.

to the ﬁrst reported case in NYC. Because this study

Acute type A aortic dissection is a life-threatening

includes no protected health information, Columbia

condition for which the only effective treatment re-

University’s Institutional Review Board advised that

quires surgical intervention, and the portal to initial

this study was exempt from Institutional Review

diagnosis is invariably the ED. In the absence of

Board submission.

emergency surgical intervention, 30-day mortality

There was a signiﬁcant and precipitous drop in

after acute type A aortic dissection ranges from 50%

the monthly surgical case volume of acute type A

to 60% (2). The COVID-19 crisis has created additional

aortic dissection from 12.8  4.6 cases/month before

challenges in EDs, such as more layers of screening

COVID-19 to 3.0 1.0 cases/month after COVID-19;

through pre-ED triage and registration, reduced in-

this change represented a 76.5% decrease in volume

dividual

timely

(Figures 1A and 1B). This decline was statistically

computed tomography scanning, and confusion of

signiﬁcant by regression analysis (9.8; 95% conﬁ-

patient

attention,

rationing

of

atypical symptoms of type A aortic dissection with

dence interval: 2.95 to 16.67; p ¼ 0.007). Low vol-

common COVID-19 presentations.

umes in 2 consecutive months (March and April
COVID-19

2020) further conﬁrmed the unusual nature of the

pandemic on the incidence of acute type A aortic

To

investigate

the

impact

of

the

observation. Given the known seasonal effect with a

dissections, we compiled data from all hospitals and

higher incidence of aortic dissections during the

health systems providing cardiac surgery in NYC

winter months (3), analysis of the volumes in the

(N ¼ 11). This approach allowed us to capture all cases

4 months (January to April) of the last 3 years

of surgical repair of acute type A aortic dissections

further conﬁrmed the unusually low volumes after

from January 1, 2018 to April 15, 2020. No change in

COVID-19.

the management of acute type A aortic dissection was

Although no causal relationship can be ﬁrmly

reported by any of the centers. All patients with acute

established among the drop in type A aortic dissec-

type A aortic dissection in NYC underwent emergency

tions, the COVID-19 outbreak in NYC, and the increase

open repair. Univariable linear regression was used to

in at-home deaths since the last week of March 2020,

calculate the estimated decrease in monthly proce-

this gives pause for thought. Several hypotheses may

dural volumes between the before–COVID-19 and

explain this observation, including patient fear of
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contracting COVID-19 if presenting to the ED, overstretched ﬁrst responders causing undue delays, or
overburdened EDs causing delayed or missed diagnoses. Importantly, this ﬁnding raises important

2. Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of
Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000;
283:897–903.
3. Mehta RH, Manfredini R, Hassan F, et al. Chronobiological patterns of acute
aortic dissection. Circulation 2002;106:1110–5.

public health concerns about the unintended consequences of the COVID-19 pandemic. It is critical, as we
adjust to the pandemic, to balance the public
health

imperative

of

social

distancing

with

the individual need to consult in the presence of
sudden severe symptoms. Furthermore, additional
resources, ranging from telemedicine to numbers of
ﬁrst responders, should be greatly increased. This

Vascular Age Is Not
Only Atherosclerosis,
it Is Also Arteriosclerosis

serves as a word of caution for cities yet to experience
a surge in COVID-19 cases, as well as for future similar

A recent issue of the Journal shined a spotlight on

events.

vascular aging by publishing a relevant longitudinal
study (1) and 2 seminars (2,3). The numerous path-
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ways connecting risk factors with several conditions
and diseases, including cardiovascular disease (CVD),
through biomarkers of vascular senescence are summarized in the Central Illustration of one of the
seminars (3). The picture suggests that vascular aging
is a driver of age-related chronic disease and mortality. Conversely, in the current American College of
Cardiology/American Heart Association (4) and European (5) guidelines for CVD prevention, assessment
of vascular aging is absent. Because factors inﬂuencing vascular age are numerous and their impact on
vascular health varies between individuals, a direct,
noninvasive assessment of vascular health is advis-
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able. Carotid ultrasound, ankle-brachial index, and
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score (4). However, these biomarkers represent the
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atherosclerotic component of vascular aging, which is
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of

Cardiology/American

Heart

Association

only one side of the coin. Arteriosclerosis is equally
relevant as a mechanism of age-related diseases, as
highlighted in the recent issue of the Journal. Arterial
stiffness (determined via carotid-femoral pulse wave
velocity) also has reclassiﬁcation potential and can
be measured with simple, noninvasive, increasingly
available techniques. Nevertheless, a number of
unmet needs are limiting the measurement of
arteriosclerosis in routine clinical practice (Table 1),
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which the VascAgeNet Cooperation in Science and
Technology (COST) Action is currently working to
address.
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